Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-13-262769
Filing Date
2013-06-18
Accepted
2013-06-18 16:24:54
Documents
4

Document Format Files

Seq Description Document Type Size
1 FILED PURSUANT TO RULE 424(B)(5) d554688d424b5.htm 424B5 291419
2 GRAPHIC g554688g19j35.jpg GRAPHIC 22226
3 GRAPHIC g554688g83d57.jpg GRAPHIC 6400
4 GRAPHIC g554688g89g09.jpg GRAPHIC 5081
  Complete submission text file 0001193125-13-262769.txt   339369
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-184829 | Film No.: 13919676
SIC: 2835 In Vitro & In Vivo Diagnostic Substances